Letter re: 'Intrapatient comparisons of efficacy in a single-arm trial of entrectinib in tumour-agnostic indications'

ESMO Open. 2021 Dec;6(6):100282. doi: 10.1016/j.esmoop.2021.100282. Epub 2021 Oct 28.

Authors

W G Sullivan¹, A J Hatswell²

Affiliations

¹ 129 Machon Bank Road, Sheffield, UK. Electronic address: willgsullivan@outlook.com.
² Delta Hat Limited, 1 Lamorna Court 43 Wollaton Road Beeston, Nottingham, UK; Department of Statistical Science, University College London Standard Institution, London, UK.

No abstract available

Publication types

Letter
Comment

MeSH terms

Benzamides / pharmacology
Benzamides / therapeutic use
Humans
Indazoles* / pharmacology
Indazoles* / therapeutic use
Neoplasms* / drug therapy

Substances

Benzamides
Indazoles
entrectinib

Associated data

ClinicalTrials.gov/NCT02568267